One possibility for the involvement of DPP III in cancer progression is its interaction with KEAP1 and the resulting upregulation of the KEAP1-NRF2 pathway, as it is known that the KEAP1-NRF2 pathway is frequently upregulated in cancer. This evidence concerns the gene KEAP1 and cancer.